Abstract: Provided are silicone microparticles including 100 parts by mass of silicone elastomer spherical microparticles having a volume average particle diameter within a range from 0.1 to 100 ?m, and 0.5 to 25 parts by mass of a polyorganosilsesquioxane that coats the surface of the silicone elastomer spherical microparticles, in which the silicone elastomer is capable of absorbing not less than 30 parts by mass of at least one oily substance selected from the group consisting of sebum, hydrocarbon oils and ester oils per 100 parts by mass of the silicone elastomer.
Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.
Type:
Grant
Filed:
July 13, 2012
Date of Patent:
January 7, 2014
Assignee:
Nusirt Sciences, Inc.
Inventors:
Michael Zemel, E. Douglas Grindstaff, II, Antje Bruckbauer
Abstract: A combination treatment, wherein a strontium-containing compound together with one or more active substances capable of reducing the incidence of bone fracture and/or increasing bone density and/or improving healing of fractured bone and/or improving bone quality are administered for use in the treatment and/or prophylaxis of cartilage and/or bone conditions.
Type:
Grant
Filed:
May 4, 2009
Date of Patent:
January 7, 2014
Assignee:
Osteologix A/S
Inventors:
Christian Hansen, Henrik Nilsson, Stephan Christgau
Abstract: Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.
Type:
Grant
Filed:
July 13, 2012
Date of Patent:
December 31, 2013
Assignee:
Nusirt Sciences, Inc.
Inventors:
Michael Zemel, E. Douglas Grindstaff, II, Antje Bruckbauer
Abstract: Disclosed are compositions including powdered green tea extract and a powdered preparation comprising polyunsaturated fatty acids. Also disclosed are methods of preparing the compositions and using the compositions in food products, as well as food products containing or that are prepared from the compositions.
Abstract: The present invention provides for methods of treating cognitive deficits resulting from interruption of blood supply and/or oxygen deficit by administering a therapeutically effective dose of a sulfonyl fluoride, such as methanesulfonyl fluoride and ethanesulfonyl fluoride. The underlying cause of the or oxygen deficit can be from stroke, trauma, carbon monoxide poisoning, and other poisonings. This method also includes co-administering with sulfonyl fluoride with a therapeutically effective dose of a second agent.
Type:
Grant
Filed:
August 14, 2002
Date of Patent:
December 31, 2013
Assignee:
Board of Regents, The University of Texas System
Inventors:
Cesario V. Borlongan, Donald E. Moss, Isabel C. Sumaya
Abstract: A cosmetic composition comprising a first emulsion and a second emulsion and optionally one or more additional emulsions, each of the two or more emulsions being discretely contained within the composition and comprising an inner phase and an outer phase, each of the two or more emulsions being independently a water-in-oil emulsion, an oil-in-water emulsion, an oil-in-oil emulsion, a polyol-in-oil emulsion, a water-in-silicone emulsion, a silicone-in-water emulsion, or a polyol-in-silicone emulsion in physical contact with at least one other emulsion, at least one of the two or more emulsions being visually distinct from the others, and each of the two or more emulsions as well as the composition being independently both physically and visually stable within the composition for at least six months at ambient temperature.
Type:
Grant
Filed:
November 18, 2009
Date of Patent:
December 24, 2013
Assignee:
Avon Products, Inc
Inventors:
Faith A. Corbo, Qi Hong, Anthony D. Gonzalez
Abstract: The present invention relates to the use of polyols of formula (I): or a salt thereof, for preventing the hair from breaking. The invention also relates to a cosmetic composition comprising at least one such polyol or a salt thereof, in a cosmetically acceptable medium, and also to a cosmetic hair treatment process using the said composition.
Type:
Grant
Filed:
May 13, 2005
Date of Patent:
December 17, 2013
Assignee:
L'Oreal
Inventors:
Frederic Leroy, Michel Philippe, Philippe Barbarat, Christian Blaise
Abstract: Articles comprising one or more calcium salts are provided. The articles can contain one or more calcium salts in an amount effective to reduce the production of TSST-1 by at least about 50% when measured by the Shake Flask Method. In certain embodiments, the one or more calcium salts can be substantially non-lethal to Staphylococcus aureus when measured by the Shake Flask Method, and/or to Lactobacillus crispatus, Lactobacillus gasseri, and/or Lactobacillus iners when measured by the Maximum Tolerated Dose Test.
Type:
Grant
Filed:
June 28, 2007
Date of Patent:
December 10, 2013
Assignee:
The Procter & Gamble Company
Inventors:
Thomas Ward Osborn, III, Fancheng Wang, Kimberly Ann Nemeth, Catherine Cornick Davis
Abstract: A cosmetic cleansing and shaving preparation which comprises a surfactant system of (i) one or more amphoteric surfactants and (ii) one or more anionic surfactants, the weight ratio (i):(ii) being greater than about 1:1. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.
Type:
Grant
Filed:
October 27, 2008
Date of Patent:
December 10, 2013
Assignee:
Beiersdorf AG
Inventors:
Horst Argembeaux, Miriam Belser, Katrin Counradi
Abstract: The present invention relates to a pharmaceutical composition including loratidine, its use in the treatment of upper respiratory mucosal congestion and a method of administration of the composition. Particularly, though not exclusively, the invention relates to a pharmaceutical composition including loratidine in an amount suitable for administration a maximum of 4 times a day, and a second active that is a hydroxyl-?-[(methylamino) methyl]-benzenemethanol, such 3-hydroxyl-?-[(methylamino) methyl]-benzenemethanol (phenylephrine), or salt thereof.
Abstract: A delivery system for inclusion in an edible composition is formulated to have at least one active component with an encapsulating material for delivering the active component upon consumption of the edible composition.
Abstract: A delivery system for inclusion in an edible composition is formulated to have at least one active component with an encapsulating material for delivering the active component when the active component is included in an edible composition and the edible composition is consumed.
Abstract: A delivery system for inclusion in an edible composition is formulated to have at least one active component with an encapsulating material for delivering the active component when the active component is included in an edible composition and the edible composition is consumed.
Type:
Grant
Filed:
May 23, 2005
Date of Patent:
November 26, 2013
Assignee:
Kraft Foods Global Brands LLC
Inventors:
Navroz Boghani, Petros Gebreselassie, Jesse J. Kiefer
Abstract: A delivery system for inclusion in an edible composition is formulated to have at least one active component with an encapsulating material for delivering the active component upon consumption of the edible composition.
Abstract: The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of an individual by administering to the individual an aqueous solution of at least calcium acetate.
Abstract: A delivery system for inclusion in an edible composition is formulated to have at least two active components with an encapsulating material for managing the release of the two actives relative to each other when used in an edible composition.
Abstract: The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of an individual by administering to the individual an aqueous solution of at least calcium acetate.
Abstract: The invention provides a composition and method to prevent and treat bedsores rapidly, efficaciously and economically. The composition comprises a novel combination of herbal extracts that has surprisingly synergistic and highly efficacious effects for the acceleration of wound healing, and which also disinfects and relieves pain in dermal wounds. The composition can also be used for the rapid healing of dermal burns and dermal cuts. The composition is comprised of extracts of aloe vera, passion flower, goldenseal, and American ginseng, and optionally includes ionic silver and mimosa extract. The treatment method comprises administering a fluid and or gel form of the composition to the wounded skin and or wound cavity therein as a prophylactic or therapeutic dose, and may be delivered by means of a wound dressing.
Abstract: The present invention relates to an oil-in-water emulsified cosmetic composition, which contains an emulsion having (A) a sphingosine represented by formula (1), (B) an acid compound selected from inorganic acids and organic acids having 5 or less carbon atoms, and (C) a ceramide represented by formula (2); and another emulsion having (D) an oil component selected from polar oils and hydrocarbon oils, and (E) a surfactant. The oil-in-water emulsified cosmetic composition contains a ceramide and is excellent in emulsion stability.